These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
183 related articles for article (PubMed ID: 10404317)
21. Prevalence of resistance phenotypes in Staphylococcus aureus and coagulase-negative isolates of venous ulcers of primary healthcare patients. Martins MA; Santos Sde L; Leão LS; Araújo NP; Bachion MM Rev Soc Bras Med Trop; 2012 Dec; 45(6):717-22. PubMed ID: 23295875 [TBL] [Abstract][Full Text] [Related]
22. In vitro activities of Daptomycin, Linezolid, and Quinupristin-Dalfopristin against a challenge panel of Staphylococci and Enterococci, including vancomycin-intermediate staphylococcus aureus and vancomycin-resistant Enterococcus faecium. Jevitt LA; Smith AJ; Williams PP; Raney PM; McGowan JE; Tenover FC Microb Drug Resist; 2003; 9(4):389-93. PubMed ID: 15000746 [TBL] [Abstract][Full Text] [Related]
23. Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy. Pantosti A; D'Ambrosio F; Bordi E; Scotto D'Abusco A; Del Grosso M Clin Microbiol Infect; 2001 Sep; 7(9):503-6. PubMed ID: 11678935 [TBL] [Abstract][Full Text] [Related]
24. [Phenotypes of macrolide, lincosamide, and streptogramin resistant Streptococcus viridans isolated from blood]. Rodríguez-Avial C; García MM; Rodríguez-Avial I; Picazo JJ Rev Esp Quimioter; 1999 Dec; 12(4):346-51. PubMed ID: 10855014 [TBL] [Abstract][Full Text] [Related]
25. Induction of ribosome methylation in MLS-resistant Streptococcus pneumoniae by macrolides and ketolides. Zhong P; Cao Z; Hammond R; Chen Y; Beyer J; Shortridge VD; Phan LY; Pratt S; Capobianco J; Reich KA; Flamm RK; Or YS; Katz L Microb Drug Resist; 1999; 5(3):183-8. PubMed ID: 10566867 [TBL] [Abstract][Full Text] [Related]
26. In vitro activity of telithromycin, quinupristin/dalfopristin, linezolid and comparator antimicrobial agents against Staphylococcus aureus clinical isolates. Millán L; Cerdá P; Rubio MC; Goñi P; Canales M; Capilla S; Oca M; Gómez-Lus R J Chemother; 2004 Jun; 16(3):230-7. PubMed ID: 15330317 [TBL] [Abstract][Full Text] [Related]
27. In vitro activity of quinupristin/dalfopristin against erythromycin-susceptible and erythromycin-resistant Streptococcus pneumoniae. Reinert RR; Kresken M; Mechery V; Lemperle M; Lütticken R Eur J Clin Microbiol Infect Dis; 1998 Sep; 17(9):662-5. PubMed ID: 9832271 [TBL] [Abstract][Full Text] [Related]
28. [Investigation of macrolide-lincosamide-streptogramin B (MLS(B)) and telithromycin resistance in clinical strains of staphylococci]. Saribaş Z; Tunçkanat F; Ozçakir O; Ercis S Mikrobiyol Bul; 2010 Apr; 44(2):177-86. PubMed ID: 20549951 [TBL] [Abstract][Full Text] [Related]
30. Phenotypes of staphylococcal resistance to macrolides, lincosamides and streptogramin B (MLS) in a Turkish university hospital. Tunçkanat F; Arikan S Zentralbl Bakteriol; 2000 Jan; 289(8):827-33. PubMed ID: 10705614 [TBL] [Abstract][Full Text] [Related]
31. Comparative in-vitro activities of quinupristin-dalfopristin against Gram-positive bloodstream isolates. Schouten MA; Hoogkamp-Korstanje JA J Antimicrob Chemother; 1997 Aug; 40(2):213-9. PubMed ID: 9301986 [TBL] [Abstract][Full Text] [Related]
33. Susceptibility to quinupristin/dalfopristin and other antibiotics of vancomycin-resistant enterococci from the UK, 1997 to mid-1999. Johnson AP; Warner M; Hallas G; Livermore DM J Antimicrob Chemother; 2000 Jul; 46(1):125-8. PubMed ID: 10882701 [TBL] [Abstract][Full Text] [Related]
34. Antipneumococcal activities of a ketolide (HMR 3647), a streptogramin (quinupristin-dalfopristin), a macrolide (erythromycin), and a lincosamide (clindamycin). Barry AL; Fuchs PC; Brown SD Antimicrob Agents Chemother; 1998 Apr; 42(4):945-6. PubMed ID: 9559816 [TBL] [Abstract][Full Text] [Related]